Company Monitoring Page for biotech

latest headlines for company on cafepharma

Big Pharma veterans at Pfizer, AstraZeneca join the great migration to biotech
Endpoints
Fri, 08/4/17 - 11:41 am
Tags:
Pfizer, AstraZeneca, Big Pharma, biotech
3 Biotech Stocks With Big News Coming
Motley Fool
Wed, 08/2/17 - 10:16 am
Tags:
biotech, Flexion, Zilretta, osteoarthritis of the knee, Zogenix, ZX008, Dravet syndrome, Keryx, chronic kidney disease, Auryxia
Biotech billionaire Soon-Shiong picks up rights to CytRx’s troubled cancer drug
Endpoints
Fri, 07/28/17 - 11:33 am
Tags:
biotech, Dr. Patrick Soon-Shiong, CytRx, NantCell, NantWorks, doxorubicin, soft tissue sarcoma
This biotech aims to transform the diagnosis of mental illness. Michael Phelps backs it. Can it really work?
Stat
Fri, 07/21/17 - 03:14 pm
Tags:
mental illness, biotech, Michael Phelps, diagnostics, Medibio, biomarkers
Biotech Stocks on Fire After Vertex News
Investopedia
Thu, 07/20/17 - 11:22 am
Tags:
biotech, Vertex Pharmaceuticals, cystic fibrosis
How Martin Shkreli used social media to fuel his short-selling shenanigans
Stat
Thu, 07/20/17 - 11:15 am
Tags:
Martin Shkreli, biotech, social media
3 Small Biotech Stocks Being Run by Proven Winners
Motley Fool
Mon, 07/17/17 - 11:15 am
Tags:
biotech, Axovant, Esperion Therapeutics, Aurinia Pharmaceuticals, Richard Glickman, David Hung, Roger Newton
Biotech Movers: Impax Shares Jump on FDA Approval for Generic Version of Concerta
TheStreet.com
Mon, 07/17/17 - 10:06 am
Tags:
biotech, Impax Labs, FDA, generics, Concerta, ADHD
Ex-GSK CEO Andrew Witty goes biotech, taking a board seat at G1
Endpoints
Thu, 07/13/17 - 09:45 am
Tags:
GSK, Andrew Witty, biotech, Pharma CEOs, G1 Therapeutics
Forget the science. These investors think they can pick biotech winners by algorithm
Stat
Wed, 07/12/17 - 09:59 am
Tags:
investors, biotech, venture capital
Biotech IPOs more than double in Q2
BioPharma Dive
Fri, 07/7/17 - 02:37 pm
Tags:
biotech, IPOs, BeyondSprings Therapeutics, Jounce Therapeutics, AnaptysBio
Feds’ case spotlights Shkreli’s disastrous biotech short — which forced him to launch Retrophin
Endpoints
Fri, 07/7/17 - 10:36 am
Tags:
Martin Shkreli, biotech, Retrophin, fraud
EuroBiotech Report: Brexit, BioNTech success, GlaxoSmithKline inks AI deal, Silence takes Alnylam to court and Shire makes cuts
Fierce Biotech
Thu, 07/6/17 - 05:58 pm
Tags:
Europe, biotech, Brexit, BioNTech, GSK, artificial intelligence, Sanofi, Exscientia, Silence Therapeutics, RNAi
3 Mid-Cap Biotech Stocks That May Be Red-Hot Takeover Candidates
Motley Fool
Wed, 07/5/17 - 07:08 pm
Tags:
biotech, M&A, Exelixis, Portola Pharmaceuticals, Intercept Pharmaceuticals
Before a biotech stock debacle, one Republican congressman made a prescient trade
Stat
Tue, 07/4/17 - 11:02 pm
Tags:
biotech, congress, Innate Immunotherapeutics
Biotech Will Lift The S&P 500 To 2,550
Seeking Alpha
Mon, 07/3/17 - 11:14 am
Tags:
biotech, S&P 500
Another biotech IPO boasting a pharma castoff rings the bell on Wall Street with $75M haul
Endpoints
Thu, 06/29/17 - 02:22 pm
Tags:
IPOs, biotech, Dova Pharmaceuticals, Mersana, Aileron
Hunt for enzymes heats up, a potential boon for biotech and beyond
Stat
Thu, 06/29/17 - 09:20 am
Tags:
enzymes, biotech, drug development, gene sequencing
5 Biotech Stocks With Major Catalysts in July
Motley Fool
Wed, 06/28/17 - 11:03 pm
Tags:
biotech, AcelRx, Zalviso, Alnylam, Patisiran, Dynavax, HEPLISAV-B, GSK, Benlysta, Puma Biotechnology, neratinib
Is This the Next Home-Run Biotech Stock?
Motley Fool
Wed, 06/28/17 - 10:42 pm
Tags:
biotech, Axovant Sciences, intepirdine, RVT-101

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.